Treace Medical Concepts, Inc., headquartered in the United States, is a pioneering company in the orthopaedic industry, specialising in innovative solutions for foot and ankle surgery. Founded in 2015, Treace has quickly established itself as a leader in the development of advanced surgical technologies, particularly in the area of flatfoot reconstruction. The company’s flagship products, including the Lapiplasty® system, are designed to address complex deformities with precision and efficiency, setting new standards in surgical outcomes. Treace's commitment to education and training for healthcare professionals further enhances its market position, making it a trusted partner in the orthopaedic community. With a focus on improving patient care and surgical techniques, Treace Medical Concepts continues to drive innovation in the field, solidifying its reputation as a key player in orthopaedic advancements.
How does Treace Medical Concepts, Inc.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Mean score of companies in the Health Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Treace Medical Concepts, Inc.'s score of 20 is lower than 63% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Treace Medical Concepts, Inc., headquartered in the US, currently does not report any carbon emissions data, as indicated by the absence of specific figures in kg CO2e. Additionally, there are no documented reduction targets or climate pledges associated with the company. This lack of data suggests that Treace Medical Concepts may not have established formal commitments to reduce its carbon footprint or engage in climate initiatives at this time. As the industry increasingly prioritises sustainability, it will be important for Treace Medical Concepts to consider developing and communicating its climate commitments in the future.
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
Treace Medical Concepts, Inc. has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.

